Cynaptec Pharmaceuticals

Vancouver, Canada

Cynaptec is a biopharmaceutical company focused on creating novel treatments for neurological and psychiatric conditions.

$6.0M raised

Jun 2025

Corporate Round

Biopharma Biotechnology Life Science

Top Investors

Lobe Sciences

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Cynaptec Pharmaceuticals

How much funding has Cynaptec Pharmaceuticals raised?

Cynaptec Pharmaceuticals has raised $6.0M in total funding. The most recent round was Corporate Round. The last funding was announced in June 2025.

Who are Cynaptec Pharmaceuticals's investors?

Cynaptec Pharmaceuticals's investors include Lobe Sciences.

Where is Cynaptec Pharmaceuticals headquartered?

Cynaptec Pharmaceuticals is headquartered in Vancouver, Canada.

What does Cynaptec Pharmaceuticals do?

Cynaptec is a biopharmaceutical company focused on creating novel treatments for neurological and psychiatric conditions.

What stage is Cynaptec Pharmaceuticals at?

Cynaptec Pharmaceuticals is at the Corporate Round stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated June 18, 2025.

MLA

"Cynaptec Pharmaceuticals — Funding & Investors." VCBacked, June 18, 2025, https://www.vcbacked.co/company/cynaptec-pharmaceuticals. Accessed July 2, 2026.

APA

VCBacked. (2025). Cynaptec Pharmaceuticals — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/cynaptec-pharmaceuticals

Wikipedia (cite web)

{{cite web |title=Cynaptec Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/cynaptec-pharmaceuticals |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated June 18, 2025.